Metagenomi Therapeutics, Inc. (MGX) stock
MGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.63−0.05 (-7.21%)
Close on Nov 17, 2026Market cap $23.84MP/E –Yield –
Metagenomi Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Metagenomi Therapeutics's market cap was $28.57M on Nov 11, 2026, against $65.71M a year earlier. Over the last 3 years it ranged from $23.90M to $239.05M, with a median of $63.55M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $28.57M | -53.0% |
| 2025 | Dec 31, 2025 | $60.83M | -55.0% |
| 2024 | Dec 31, 2024 | $135.13M | – |
See a number that looks wrong?